首页> 外国专利> PHENYL Compound, use of said Compound for the preparation of a Medicine Compound isotopically marked, Diagnostic agent, Pharmaceutical composition, Process for Preparation of said compound and Compound for exclusive use in this procedure

PHENYL Compound, use of said Compound for the preparation of a Medicine Compound isotopically marked, Diagnostic agent, Pharmaceutical composition, Process for Preparation of said compound and Compound for exclusive use in this procedure

机译:苯酚化合物,该化合物在制备经同位素标记的药物中的用途,诊断剂,药物组合物,该化合物的制备方法和本方法专用的化合物

摘要

A phenyl compound according to formula (1) in which each of m and n is independently an integer of 0û3 and one or more of the hydrogens of said alkylene chain may be optionally substituted with any of C1-6 alkyl, C1 alkoxy -6 or hydroxy or one more of the methylene groups can be optionally substituted with a heteroatom such as O, N or S; R1 is selected from hydrogen, a C1-6 alkyl, C2-6 alkenyl, straight or branched C3-8 cycloalkyl, (C4-8 alkyl-cycloalkyl), where alkyl is C1-2 alkyl and cycloalkyl is C3-6 cycloalkyl, R2 is selected from any of (i) hydrogen; (ii) a C1-6 alkyl,1. Alquenilo c2-6 plasma c2-6, straight or scattered (III) [(CH2) q-arilo]; (IV) [(CH2) r-heterogeneities, heterogeneities have 5 to 10 atoms, heterogeneities are selected from any atom; Here, arilo and heretics can be optional, independently replaced by one or two alternatives, each of which is defined below, in addition, each of which is a whole 0-3; (V) c3-10 cyclododecene, 1. It can choose to contain one or more unhealthy parts, and can choose to be replaced by one or more heteromorphic parts. The heteromorphic part has 5 to 10 atoms, and the heteromorphic part is selected from any heteromorphic part;Here, arilo and heterosexuality can be optional and can be replaced by one or two alternatives. Here, the definition of each alternative and heterosexuality is as follows: (VI) selective and independent arilo C6-10, which is replaced by one or more heteromorphic (s) with 5 to 10 atoms, selected from any heteromorphic, N and O; heteromorphic atoms can be replaced by one or two substitutes, each of which is defined as follows; (VII) heteromorphism of 5 to 10 atoms, and heteromorphism selected from any one s, N and O;Among them, arilo and heretics can be optional, independently replaced by one or two alternatives, and each alternative and the alternatives defined below: or R1 and R2 can arbitrarily form an aperiodic ring, which can include optional saturation or unsaturated; R3 can be selected from any one of (I) hydrogen compounds; and (II) a tar. C1-6, alquenilo c2-6, rectum or branch c2-6, or c2-6 tar (III) arilalquilo C6-10, wherein arilo can be replaced by one or more 5 to 10 atom heteroatoms selected from any s, N, and O;Aries and non Aries may be replaced by one or two substitutes, and each substitute and non Aries (c5-10 tar) shall be replaced as defined in (IV) of the following definitions,Among them, heteromorphic atoms are 5 to 10, and heteromorphic atoms are selected from any s, N and O; negative and heteromorphic atoms can be optional and independently replaced by one or two substitutes, Each of them (V) c3-10 cyclododecane, as defined below, contains one or more unhealthy substances, which can be replaced by one or more heteromorphic atoms of 5 to 10 atoms. Heteromorphic atoms can be selected from any s, N and o. arilo and heteromorphic atoms can be selected independently. Replace with one or two substitutes, and in each case and as defined below; (VI) [cycloquilo C3-6 - (CH2) q],where q is an integer from 1 to 3; R4 is selected from (i) hydrogen; (ii) a C1-6 alkyl, C2-6 alkenyl or straight or branched C2-6 alkynyl, (iii) C6-10 aralkyl where the aryl may be optionally substituted with one or more heteroaryl (s) of 5 to 10 atoms and where the heteroatom is selected from any of S, N and O; and where aryl and heteroaryl may be optionally and independently substituted with 1 or 2 Y substituents, where each Y is as defined below; (iv) heteroaryl (C5-10 alkyl),1. Heteromorphism has 5 to 10 atoms. Heteromorphism atoms are selected from any s, N and o. arilo and heteromorphism atoms can be optional and independently replaced by 1 or 2 substitutes, each substitute and the substitute defined below; (v) C3-10 cyclododecane, optionally containing one or more unhealthy substances, may be replaced by one or more heteroatoms of 5 to 10 atoms, which may be selected from any one s, N and O, in which case arilo and heteroatoms may optionally or independently be replaced by one or two substitutes, in which case 1. Each as defined below;(VI) selective and independent arilo C6-10, which is replaced by one or more heteromorphic (s) with 5 to 10 atoms, selected from any heteromorphic, N and O; heteromorphic atoms can be replaced by one or two substitutes, each of which is defined as follows; (VII) heteromorphism of 5 to 10 atoms, selected from any s, N and O; arilo and heteromorphism can be optional, independently replaced by 1 or 2 substitutes, each of which and the substitutes defined below; R5 selected from (I) hydrogen; (II) C1-6 alquenilo c2-6 coke oil;C2-6 alkenyl or straight or branched C2-6 alkynyl, (iii) arylalkyl C6-10, where the aryl may optionally be substituted with one or more heteroaryl (s) of 5 to 10 atoms and where the heteroatom is selected from any of S, N and O; and where aryl and heteroaryl may be optionally and independently substituted with 1 or 2 Y substituents, where each Y is as defined below; (iv) heteroaryl (C5-10 alkyl),where the heteroaryl has from 5 to 10 atoms and where the heteroatom is selected from any of S, N and O and where aryl and heteroaryl can be optionally and independently substituted with 1 or 2 substituents Y, where each Y is as defined later. (v) C3-10 cycloalkyl, which optionally contains one or more unsaturations and is optionally substituted with one or more heteroaryl (s) of 5 to 10 atoms and where the heteroatom is selected from any of S, N and O; and where aryl and heteroaryl may be optionally and independently substituted with 1 or 2 Y substituents, where each Y is as defined below; (vi) aryl C5-10,optionally and independently substituted with one or more heteroaryl (s) having from 5 to 10 atoms and where the heteroatom or atoms are selected from any of S, N and O; and where heteroaryl may be optionally and independently substituted with 1 or 2 Y substituents where each Y is as defined below; (vii) heteroaryl of 5 to 10 atoms and where the heteroatom is selected from any of S, N and O and where aryl and heteroaryl may be optionally and independently substituted with 1 or 2 Y substituents, where each Y is as defined later; (viii) structures (2) or (3) where each of R7, R8, R9,R10 and R11 are selected independently from (a) hydrogen; (b) C1-6 alquenilo c2-6 tar or c2-6 straight tar or branch; (c) arilalquilo C 6-10; (c) arilalquilo C6-10, where arilo can be replaced by one or more 5 to 10 atom heteromorphisms selected from any s, N and O; arilo and Heretics can be optional and can be replaced independently by one or two alternatives, in which case each alternative is defined below; (d) heretics (c5-10 tar)Where there are 5 to 10 atoms in heteromorphism, heteromorphism atoms are selected from any s, N and o. arilo and heteromorphism atoms can be optional and independently replaced by one or two substitutes, where each of them is (E) cycloquilo c3-10, It can selectively contain one or more unhealthy substances, which can be replaced by one or more heteromorphic atoms of 5 to 10 atoms. Heteromorphic atoms can be selected from any s, N and O. cathode and heteromorphic atoms can be replaced by one or two substitutes, which can be replaced independently, There, each as defined below;(f) C6-10 aryl optionally and independently substituted with one or more heteroaryl (s) having from 5 to 10 atoms and where the heteroatom (s) are selected from any of S, N and O and where the heteroaryl may be optional and independently substituted with 1 or 2 Y substituents, where each Y is as defined below; (ix) structure (4) or R4 and R5 can optionally form a heterocyclic ring that can be optionally saturated or unsaturated. Each Y is independently selected from hydrogen, CH3; - (CH2) p1CF3 halogen, alkoxy, C1-3; hydroxy; -NO2; -OCF3; -CONRaRb, -COORa, -CORa, - (CH2) p2NraRbû (CH2) p3CH3, (CH2) p4SORaRb, - (CH2) p5SO2Ra,C4-8 (alkyl-cycloalkyl) where alkyl is C1-2 alkyl and cycloalkyl is C3-6 cycloalkyl, where 1 or 2 heteroaryls have 5 to 10 atoms and the heteroatom is selected from S, N and O, as well as oxides such as N-oxides or sulfoxides and where Ra and Rb is independently selected from hydrogen, a branched or straight C1-6 alkyl, C1-6 alkenyl or C3-8 cycloalkyl, and where each of p1, p2, p3, p4, p5, and p6 is independently 0.1 or 2, as well as the pharmaceutically acceptable salts of the compounds of formula 1 and also the isomers, hydrates, isoforms and prodrugs thereof; its use for the manufacture of a medicine, diagnostic agent,It contains its pharmaceutical ingredients, preparation process, intermediate compounds, and its sole use is in the preparation of Formula 1 compounds and treatment methods. These compounds contribute to the treatment of, in particular, various painful disorders, such as chronic pain, acute pain, cancer-related pain, and induced pain.
机译:根据式(1)的苯基化合物,其中m和n各自独立地为0û3的整数,并且所述亚烷基链的一个或多个氢原子可以任选地被C 1-6烷基,C 1烷氧基-6或C 1-6中的任何一个取代。羟基或一个或多个亚甲基可任选地被杂原子如O,N或S取代; R1选自氢,C1-6烷基,C2-6链烯基,直链或支链C3-8环烷基(C4-8烷基-环烷基),其中烷基为C1-2烷基且环烷基为C3-6环烷基,R2选自(i)氢中的任何一个; (ii)C 1-6烷基,1。 Alquenilo c2-6血浆c2-6,直或分散(III)[(CH2)q-arilo]; (IV)[(CH2)r-异质性,异质性有5到10个原子,异质性选自任何原子;在这里,arilo和Heretics可以是可选的,可以单独替换为一个或两个替代项,每个替代项在下面定义,此外,每个替代项均为0-3; (V)c3-10环十二碳烯,1.它可以选择包含一个或多个不健康部分,并且可以选择被一个或多个异质部分取代。异晶部分具有5至10个原子,并且该异晶部分选自任何异晶部分;在此,arilo和异性恋可以是可选的,并且可以被一个或两个替代替换。在此,每个替代和异性的定义如下:(VI)选择性和独立的芳基C6-10,其被一个或多个具有5至10个原子的杂态取代,所述杂态选自N,O。异质原子可以被一个或两个取代基取代,每个取代基定义如下; (VII)5至10个原子的异质性,以及选自s,N和O中的任何一种;其中arilo和Heretics是可选的,可独立地被一个或两个替代物取代,并且每个替代物和以下定义的替代物:或R1和R2可任意形成非周期性环,该环可包括任选的饱和或不饱和环; R 3可以选自(I)氢化合物中的任何一种; (II)焦油。 C1-6,alquenilo c2-6,直肠或分支c2-6或c2-6 tar(III)arilalquilo C6-10,其中arilo可被一个或多个5至10个选自任何s,N, O,白羊座和非白羊座可以被一个或两个取代基取代,并且每个取代基和非白羊座(c5-10焦油)应按以下定义(IV)的定义进行取代,其中,同质原子为5至10,并且多晶原子选自任何s,N和O;负原子和异晶原子可以是可选的,并分别被一个或两个取代基取代,它们各自(V)定义如下的c3-10环十二烷含有一种或多种不健康的物质,这些物质可以被一个或多个5个同质原子取代到10个原子异形原子可以选自任何s,N和o。杂原子和杂原子可以独立选择。用一种或两种替代物替换,并分别根据以下定义; (VI)[环基C3-6-(CH2)q],其中q是1至3的整数; R4选自(i)氢; (ii)C1-6烷基,C2-6烯基或直链或支链C2-6炔基,(iii)C6-10芳烷基,其中芳基可任选地被一个或多个5至10个原子的杂芳基取代;和其中杂原子选自S,N和O中的任何一个;其中芳基和杂芳基可以任选地和独立地被1或2个Y取代基取代,其中每个Y如以下所定义; (iv)杂芳基(C5-10烷基),1。异同具有5至10个原子。异晶原子选自任何s,N和o。杂原子和杂晶原子可以是可选的,可以独立地被1个或2个取代基取代,每个取代基和下面定义的取代基; (v)C3-10环十二烷,可选地包含一种或多种不健康的物质,可以被一个或多个5至10个原子的杂原子取代,该杂原子可以选自s,N和O中的任何一个,在这种情况下,arilo和杂原子可以任选地或独立地被一个或两个取代基取代,在这种情况下为1。各自定义如下;(VI)选择性和独立的arilo C6-10,被一个或多个具有5至10个原子的多晶型所取代来自任何异质的N和O;异质原子可以被一个或两个取代基取代,每个取代基定义如下; (VII)5至10个原子的异质性,选自任何s,N和O; arilo和heteromorphism可以是可选的,可以分别被1个或2个替换物取代,每个替换物和下面定义的替换物; R5选自(I)氢; (II)C1-6 Alquenilo c2-6焦油; C2-6烯基或直链或支链C2-6炔基,(iii)芳烷基C6-10,其中芳基可任选地被一个或多个杂芳基取代5-10个原子,其中杂原子选自S,N和O中的任何一个;其中芳基和杂芳基可以任选地和独立地被1或2个Y取代基取代,其中每个Y如以下所定义; (iv)杂芳基(C5-10烷基),其中杂芳基具有5至10个原子,并且杂原子选自S,N和O中的任何一个,并且其中芳基和杂芳基可以任选地并且独立地被1或2个取代基Y取代,其中每个Y如后定义。 (v)C3-10环烷基,其任选地包含一个或多个不饱和键,并且任选地被一个或多个5至10个原子的杂芳基取代,并且其中杂原子选自S,N和O中的任何一个;其中芳基和杂芳基可以任选地和独立地被1或2个Y取代基取代,其中每个Y如以下所定义; (vi)芳基C5-10,其任选地且独立地被一个或多个具有5至10个原子的杂芳基取代,并且其中一个或多个杂原子选自S,N和O中的任何一个;以及其中杂芳基可以任选地并且独立地被1或2个Y取代基取代,其中每个Y如以下所定义; (vii)5至10个原子的杂芳基,其中杂原子选自S,N和O中的任何一个,并且其中芳基和杂芳基可以任选地并且独立地被1或2个Y取代基取代,其中每个Y如后定义; (viii)结构(2)或(3),其中R 7,R 8,R 9,R 10和R 11各自独立地选自(a)氢; (b)C1-6 Alquenilo c2-6焦油或c2-6直焦油或分支; (c)arilalquilo C 6-10; (c)arilalquilo C6-10,其中arilo可被选自s,N和O中的一个或多个5至10个原子异质性取代; arilo和Heretics可以是可选的,并且可以由一个或两个替代项单独替换,在这种情况下,每个替代项均在下面定义; (d)异质性(c5-10 tar)当异质性中有5至10个原子时,异质性原子选自s,N和o中的任何一个。杂原子和杂晶原子可以是可选的,并且可以分别被一个或两个取代基取代,其中每个取代基为(E)环基c3-10,它可以选择性地包含一种或多种不健康的物质,可以被一个或多个杂原子取代。 5至10个原子。杂晶原子可以选自任何s,N和O.阴极和杂晶原子可以被一个或两个取代基取代,这些取代基可以独立取代,其中每个定义如下;(f)C6-10芳基,可选且独立地取代具有一个或多个具有5至10个原子的杂芳基,并且其中杂原子选自S,N和O中的任何一个,并且其中杂芳基可以是任选的并且独立地被1个或2个Y取代基取代,其中每个Y的定义如下; (ix)结构(4)或R 4和R 5可以任选地形成可以任选地为饱和或不饱和的杂环。每个Y独立地选自氢CH 3; -(CH 2)p1CF3卤素,烷氧基,C1-3;羟基-NO 2; -OCF3; -CONRaRb,-COORa,-CORa,-(CH2)p3CH3,(CH2)p4SORaRb,-(CH2)p5SO2Ra,C4-8(烷基-环烷基),其中烷基为C1-2烷基,环烷基为C3- 6环烷基,其中1或2个杂芳基具有5至10个原子,并且杂原子选自S,N和O,以及氧化物(例如N-氧化物或亚砜),并且Ra和Rb独立地选自氢,支链或直链C 1-6烷基,C 1-6烯基或C 3-8环烷基,以及其中p1,p2,p3,p4,p5和p6各自独立地为0.1或2以及下式化合物的可药用盐1及其异构体,水合物,同工型和前药;其用于制造药物,诊断剂的用途,它包含其药物成分,制备方法,中间体化合物,并且其唯一用途是用于制备式1化合物和治疗方法。这些化合物特别有助于治疗各种疼痛疾病,例如慢性疼痛,急性疼痛,与癌症有关的疼痛和诱发性疼痛。

著录项

  • 公开/公告号AR030008A1

    专利类型

  • 公开/公告日2003-08-13

    原文格式PDF

  • 申请/专利权人 ASTRA PHARMA INC.;

    申请/专利号AR1999P102987

  • 发明设计人

    申请日1999-06-22

  • 分类号C07C279/18;C07C311/18;C07C279/12;C07C311/16;C07D333/54;A61K31/155;A61K31/18;A61K31/38;A61K51/00;A61K49/00;A61P29/00;

  • 国家 AR

  • 入库时间 2022-08-22 00:04:01

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号